UC San Diego Health Physicians Top the List
October 2, 2023
More than 100 UC San Diego Health Physicians named “Top Docs” in annual survey.
Your search for “Kidney disease” returned 146 results
Modest Alcohol Use Lowers Risk and Severity of Some Liver Disease
April 19, 2012
…with nonalcoholic fatty liver disease (NALFD) who consume alcohol in modest amounts – no more than one or two servings per day – are half as likely to develop hepatitis as non-drinkers with the same condition, reports a national team of scientists led by researchers at the University of California,…
Renowned Surgeon Christopher J. Kane Named to Joseph D. Schmidt, MD Presidential Chair in Urology
November 16, 2015
Christopher J. Kane, M.D., a renowned specialist in prostate cancer and an expert in robotic and other minimally invasive procedures for urologic surgery at the University of California, San Diego, has been appointed the inaugural holder of the Joseph D. Schmidt, MD Presidential Chair in Urology in the School of…
Blocking Neuron Signaling Pathway Could Lead to New Treatments for Peripheral Neuropathy
January 17, 2017
…Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced…
Rohit Loomba, MD, Named Chief of the Division of Gastroenterology and Hepatology
June 13, 2023
Loomba will lead the division at UC San Diego School of Medicine, building upon a team that shines a light on UC San Diego Health’s tripartite mission.
Selective, Toxin-Bearing Antibodies Could Help Treat Liver Fibrosis
July 12, 2021
UC San Diego researchers discovered that immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and cirrhosis, in mouse models of human disease.
New Genetic Associations in Pediatric NAFLD Affect Both Risk and Severity
June 27, 2022
In a pair of studies, UC San Diego School scientists have deepened investigations into the genetic origins of nonalcoholic fatty liver disease in children, describing multiple gene variants that contribute to disease risk.
UC San Diego and Rady Children’s Hospital Join Nationwide Long-COVID Study
August 5, 2022
Researchers at University of California San Diego School of Medicine and Rady Children’s Hospital-San Diego have joined a nationwide study to better understand the long-term impact of COVID-19 on patients in the United States across all demographic groups.
Remote Italian Village Could Harbor Secrets of Healthy Aging
March 29, 2016
To understand how people can live longer throughout the world, researchers at University of California, San Diego School of Medicine have teamed up with colleagues at University of Rome La Sapienza to study a group of 300 citizens, all over 100 years old, living in a remote Italian village nestled…
UC San Diego Receives $9 Million in Grants to Pinpoint Cellular Cause of Type 1 Diabetes
August 13, 2019
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.
